000 | 01776 a2200517 4500 | ||
---|---|---|---|
005 | 20250513203252.0 | ||
264 | 0 | _c20000328 | |
008 | 200003s 0 0 eng d | ||
022 | _a1078-0432 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLah, T T | |
245 | 0 | 0 |
_aCathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2000 |
||
300 |
_a578-84 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xmortality |
650 | 0 | 4 |
_aCathepsin B _xanalysis |
650 | 0 | 4 |
_aCathepsin D _xanalysis |
650 | 0 | 4 | _aCathepsin L |
650 | 0 | 4 |
_aCathepsins _xanalysis |
650 | 0 | 4 | _aCysteine Endopeptidases |
650 | 0 | 4 | _aEndopeptidases |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 |
_aReceptors, Progesterone _xanalysis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aCercek, M | |
700 | 1 | _aBlejec, A | |
700 | 1 | _aKos, J | |
700 | 1 | _aGorodetsky, E | |
700 | 1 | _aSomers, R | |
700 | 1 | _aDaskal, I | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 6 _gno. 2 _gp. 578-84 |
|
999 |
_c10644747 _d10644747 |